ERAS - Erasca, Inc.
NEXT EARNINGS:
Mar 19, 2026
(in 22 days)
EPS Est: $-0.11
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$9.60
DETAILS
HIGH:
$12.00
LOW:
$5.00
MEDIAN:
$10.00
CONSENSUS:
$9.60
DOWNSIDE:
29.46%
Market Cap:
4.21B
Volume:
3,555,460
Avg Volume:
5,306,946
52 Week Range:
1.01-13.8
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.22
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
103
IPO Date:
2021-07-16
EPS (TTM):
-0.69
P/E Ratio:
-3.63
Revenue (TTM):
N/A
Total Assets:
502.53M
Total Debt:
51.89M
Cash & Equiv:
67.74M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-33.3%
Debt/Equity:
0.12
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-12 | $-0.11 | $-0.11 | 0.0% | — | — | — |
| 2025-08-12 | $-0.12 | $-0.12 | 0.0% | — | — | — |
| 2025-05-13 | $-0.11 | $-0.12 | +8.3% | — | — | — |
| 2025-03-20 | $-0.11 | $-0.12 | +8.3% | — | — | — |
| 2024-11-12 | $-0.11 | $-0.17 | +35.3% | — | — | — |
| 2024-08-12 | $-0.29 | $-0.17 | -70.6% | — | — | — |
| 2024-05-08 | $-0.23 | $-0.21 | -9.5% | — | — | — |
| 2024-03-27 | $-0.20 | $-0.24 | +16.7% | $5.6M | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (161.65M) | (125.04M) | (242.81M) | (122.76M) | (101.66M) | (12.04M) |
| EPS | -0.69 | -0.83 | -1.99 | -1.03 | -0.85 | -0.10 |
| Total Assets | 502.53M | 395.30M | 514.91M | 501.42M | 124.83M | 55.51M |
| Total Debt | 51.89M | 55.86M | 55.10M | 18.79M | 2.99M | 3.69M |
| Cash & Equivalents | 67.74M | 93.08M | 284.22M | 360.49M | 65.38M | 29.58M |
| Operating Cash Flow | (109.42M) | (101.22M) | (103.26M) | (79.60M) | (32.69M) | (10.38M) |
| Free Cash Flow | (131.98M) | (102.99M) | (119.81M) | (98.48M) | (71.38M) | (10.97M) |
| FCF per Share | -0.56 | -0.69 | -0.98 | -0.83 | -0.60 | -0.09 |
| Book Value | 423.50M | 316.69M | 411.85M | 456.53M | 107.42M | (13.60M) |
| Cash & ST Investments | 298.31M | 312.35M | 435.62M | 414.48M | 118.70M | 50.37M |
| ROC Equity | -0.38 | -0.39 | -0.59 | -0.27 | -0.95 | N/A |